drugset / Trial / NCT00960141

A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

NCT00960141

Phase 3 Completed 829 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A study of the ability of montelukast to improve signs and symptoms of seasonal allergic rhinitis compared with placebo. Loratadine is included in the study as an active control.

Timeline

Start
2000-08
Primary completion
2000-10
Completion
2000-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loratadine Small molecule 10 mg Oral
Subject Montelukast Other / unclassified 10 mg Oral